Decision on Covishield gap taken transparently, based on scientific evidence: Centre
, 20 news, 2 views
The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday.
There was no dissenting voice among the members of the National Technical Advisory Group on Immunization (NTAGI ), he said, according to a tweet by the Union Health Ministry.
The government had on May 13 said it has accepted the COVID-19 Working Group’s recommendation and extended the gap between the two doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks.